Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Emetrol Chewables
- Development stage
- Unknown
- Lead developer
- WellSpring Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Emetrol Chewables is an over-the-counter (OTC) oral medication developed by WellSpring Pharmaceutical for the rapid relief of nausea associated with an upset or sour stomach, particularly due to overindulgence in food and drink. The active ingredient in Emetrol Chewables is sodium citrate dihydrate (230 mg per tablet), which acts as an antacid to neutralize excess stomach acid and calm stomach discomfort. Unlike Emetrol Liquid, which contains phosphorated carbohydrates (dextrose, fructose, and phosphoric acid), Emetrol Chewables relies on sodium citrate dihydrate to neutralize acid and alleviate nausea without causing drowsiness.
- Brand names
- Emetrol Chewable Rapid Nausea ReliefEmetrol ChewablesEmetrol Chewables LemonEmetrol Chewables Mixed BerryEmetrol Chewables Orange
- Other names
- Emetrol Chewable Tablets
Beyond the preview
Go deeper on Emetrol Chewables.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Emetrol Chewables.